Personalized Lymphoma Vaccine
Usually, follicular lymphoma can be suppressed with chemotherapy, but after a year, relapses are characteristic of this type of cancer. Patients who received an immunostimulator and a foreign protein with their own marker lived without relapses for 44 months. This is a very significant achievement, since previously with follicular lymphoma it was not possible to increase either the duration of the relapse-free period or the survival rate.
01.06.2009